CAS: 228559-41-9; 1-(2,4-Difluorophenyl)-3-(4-((6,7-Dimethoxyquinolin-4-yl)Oxy)-2-Fluorophenyl)Urea

该化合物是一个合成有机化合物,其特征是复杂的分子结构,包括一个尿素功能组和多个芳香环.该化合物在苯环上有两个氟原子,有助于其电子特性和潜在的生物活动.一种quinoline mody,连同甲氧基组的存在,表明它可能具有有趣的药理特性,可能作为动脉抑制剂或具有其他治疗用途.其溶性与稳定性可能受到芳香环上的分体的影响,这也可能影响其与生物目标的相互作用.该化合物的合成通常涉及多步的有机反应,其特征可以使用NMR,质量光谱测定和X射线晶学等技术进行.

结构式图片

上下游产品

2,4-diflurophenylis°Cyanate 4-[(6,7-Dimethoxy-4-quinolyl)oxy]-2-fluoroaniline 6,7-dimethoxy-4-chloroquinoline 2-amino-4,5-dimethoxyacetophenone

合成工艺路线路线简述

    2'-氨基-4',5'-二甲氧基苯乙酮置于sodium Methylate,氯化铵,锌,三氯氧磷体系中,用 甲醇,乙二醇二甲醚,氯苯,甲苯 用作溶剂,化学反应 23.67H,反应生成Ki 8751; N-(2,4-二氟苯基)-N'-[4-[(6,7-二甲氧基-4-喹啉基)氧基]-2-氟苯基]脲
    参考文献:Novel Potent Orally Active Selective Vegfr-2 Tyrosine Kinase Inhibitors: Synthesis,Structure−activity Relationships,And Antitumor Activities Of N-Phenyl-N'-{4-(4-Quinolyloxy)Phenyl}Ureas
    标题:Novel Potent Orally Active Selective Vegfr-2 Tyrosine Kinase Inhibitors: Synthesis,Structure−activity Relationships,And Antitumor Activities Of N-Phenyl-N'-{4-(4-Quinolyloxy)Phenyl}Ureas
    摘要:N-Phenyl-N'-{4-(4-Quinolyloxy)Phenyl}Ureas Were Found To Be A Novel Class Of Potent Inhibitors For The Vascular Endothelial Growth Factor Receptor 2 (Vegfr-2) Tyrosine Kinase Through Synthetic Modifications Of A Lead Compound And Structure-Activity Relationship Studies. A Representative Compound 6Ab,Termed Ki8751,Inhibited Vegfr-2 Phosphorylation At An Ic50 Value Of 0.90 Nm,And Also Inhibited The Pdgfr Family Members Such As Pdgfr(X And C-Kit At 67 Nm And 40 Nm,Respectively. However,6Ab Did Not Have Any Inhibitory Activity Against Other Kinases Such As Egfr,Hgfr,Insulinr And Others Even At 10000 Nm. 6Ab Suppressed The Growth Of The Vegf-Stimulated Human Umbilical Vein Endothelial Cell (Huvec) On A Nanomolar Level. 6Ab Showed Significant Antitumor Activity Against Five Human Tumor Xenografts Such As Gl07 (Glioma),St-4 (Stomach Carcinoma),Lc6 (Lung Carcinoma),Dld-1 (Colon Carcinoma) And A375 (Melanoma) In Nude Mice And Also Showed Complete Tumor Growth Inhibition With The Lc-6 Xenograft In Nude Rats Following Oral Administration Once A Day For 14 Days At 5 Mg/kg Without Any Body Weight Loss.
    Doi:10.1021/jm030427R

    海关参考信息

    上海与昂化工有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.twochem.com
    电话: 021-021-58111628 15800915896👤
    📞上海与昂化工有限公司 ⚠️参考联系方式

    销售电话:021-021-58111628 15800915896
    邮箱:sales@twochem.com
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别 ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    第 1 / 1 页
    现货

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    主要参考文献


    1: Pan Z, Fukuoka S, Karagianni N, Guaiquil VH, Rosenblatt MI. Vascular endothelial growth factor promotes anatomical and functional recovery of injured peripheral nerves in the avascular cornea. FASEB J. 2013 Jul;27(7):2756-67. doi: 10.1096/fj.12-225185. Epub 2013 Apr 8.
    2: Xu C, Wu X, Zhu J. VEGF promotes proliferation of human glioblastoma multiforme stem-like cells through VEGF receptor 2. ScientificWorldJournal. 2013;2013:417413. doi: 10.1155/2013/417413. Epub 2013 Feb 28.
    3: Akiyama K, Ohga N, Hida Y, Kawamoto T, Sadamoto Y, Ishikawa S, Maishi N, Akino T, Kondoh M, Matsuda A, Inoue N, Shindoh M, Hida K. Tumor endothelial cells acquire drug resistance by MDR1 up-regulation via VEGF signaling in tumor microenvironment. Am J Pathol. 2012 Mar;180(3):1283-93. doi: 10.1016/j.ajpath.2011.11.029. Epub 2012 Jan 13. doi: 10.1002/ijc.26179. Epub 2011 Aug 3. doi: 10.1002/jcp.22491.

    合成参考文献


    参考文献:10.1124/mol.119.115964
    摘要:Lee TD, Lee OW, Brimacombe KR, Chen L, Guha R, Lusvarghi S, Tebase BG, Klumpp-Thomas C, Robey RW, Ambudkar SV, Shen M, Gottesman MM, Hall MD. A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein. Molecular Pharmacology. 2019 Nov;96(5):629–40. doi: 10.1124/mol.119.115964.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知